Skip to the page

Data / Form D filings / Obatala Sciences, Inc.

Obatala Sciences, Inc.: Form D filings

Obatala Sciences, Inc., a biotechnology company in New Orleans, LA, filed 2 Form D notices with the SEC between 2020 and 2021. The latest, on January 15, 2021, reports $535,000 sold of a $1.5 million offering to 10 investors.

Find out what Obatala Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2000 LAKESHORE DRIVE, #4020, New Orleans, LA, 70148
Phone
(504) 300-0266
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2017
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1828551

The full lists. Form D filings in Louisiana: 144 rows, $7.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 15, 2021Amendment$1,500,000$535,000$965,00010Sep 30, 2020sec.gov
Oct 15, 2020New notice$750,000$200,000$550,00010Sep 30, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeffrey GimbleExecutive Officer, Director
Trivia FrazierExecutive Officer, Director
Xiying Wu GimbleExecutive Officer, Director

Other biotechnology companies in Louisiana that filed recently

Every Form D from the week of Jan 11, 2021 · All recent filings in Louisiana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Obatala Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.